| FMCAX | VIMAX | FMCAX / VIMAX | |
| Total Expense Ratio | 1.17 | 0.05 | 2,340% |
| Annual Report Gross Expense Ratio | 1.17 | 0.05 | 2,340% |
| Fund Existence | 30 years | 24 years | - |
| Gain YTD | 4.314 | 7.227 | 60% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 199B | 1% |
| Annual Yield % from dividends | 0.07 | 1.49 | 4% |
| Returns for 1 year | -1.42 | 3.13 | -45% |
| Returns for 3 years | 19.36 | 35.55 | 54% |
| Returns for 5 years | 19.00 | 46.13 | 41% |
| Returns for 10 years | 40.25 | 134.11 | 30% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LICPX | 18.03 | N/A | N/A |
| Lord Abbett International Equity P | |||
| UOPIX | 137.35 | N/A | N/A |
| ProFunds UltraNASDAQ-100 Inv | |||
| RGSVX | 15.15 | N/A | N/A |
| ClearBridge Global Infrastructure Inc IS | |||
| RPMYX | 11.92 | N/A | N/A |
| Reinhart International PMV Advisor | |||
| JFNSX | 77.32 | -0.16 | -0.21% |
| Janus Henderson Global Life Sciences S | |||